Clinical Trial of Cuban Asthma Vaccine to Begin
Havana, Cuba. – After demonstrating its safety and tolerance, Phase II of the clinical trial of the Cuban allergy vaccine Prolinem-DS for asthmatic patients will soon begin.
Dr. Raúl Lázaro Castro Almarales, second-degree specialist in Allergy, declared that this new-generation immunogen has a patent in several countries.
Developed by the National Biopreparations Center and the Finlay Institute, Prolinem-DS reduces the number of injections from 23 to 6 every 14 days, compared to the Valergén vaccine, which is used to treat allergic asthma through injectable and sublingual routes, Castro Almarales said.
Those interested can go to allergy consultations offered in the Primary Health Care to be evaluated by the specialist and transferred to either of the two hospitals.
(Taken from Radio Reloj in Spanish)
Written by Radio Grito de Baire
